Analysts Bullish On Cannabis Co. TerrAscend Post-Earnings: Raised Targets And Upgraded Ratings

In the wake of TerrAscend Corp. TSNDF's impressive third-quarter earnings, several analysts have revised their ratings and price targets, signaling renewed optimism for the cannabis company's prospects.

Clarus Securities Raises Target Price

Noel Atkinson and George Ulybyshev from Clarus Securities have raised their target price for TerrAscend. Reflecting their confidence, the new target stands at $3.50, up from the previous $3.25. They maintain a "Buy" rating, emphasizing the company's strong performance and potential for growth.

Echelon Capital Markets Upgrades To Speculative Buy

Echelon Capital Markets has upgraded TerrAscend from "Hold" to "Speculative Buy," setting a new target price at C$2.75, previously C$2.30. Their analysis points to the company's operational turnaround and robust Q3 results as key drivers for this positive reassessment. Echelon highlights TerrAscend's potential, suggesting the current stock price offers a compelling entry point for investors.

ATB Capital Markets' Optimistic Outlook

ATB Capital Markets issued an "Outperform" rating, with a revised price target of C$4.00, an increase from the former C$3.50 target. This adjustment indicates a strong belief in TerrAscend's continued growth and operational efficiency, signaling a bullish outlook for the company's future performance.

Canaccord Genuity Boosts Price Target

Matt Bottomley from Canaccord Genuity reiterated a 'Buy' rating for TerrAscend, boosting the price target to C$3.25 from the earlier C$2.85. This revision follows TerrAscend's promising financial results and operational milestones, underlining the company's upward trajectory in the competitive cannabis market.

Image generated with AI